151 related articles for article (PubMed ID: 11919240)
21. Tumour vascularity is not a prognostic factor for cutaneous melanoma.
Barnhill RL; Busam KJ; Berwick M; Blessing K; Cochran AJ; Elder DE; Fandrey K; Karaoli T; White WL
Lancet; 1994 Oct; 344(8931):1237-8. PubMed ID: 7934572
[No Abstract] [Full Text] [Related]
22. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
23. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
24. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.
Piérard GE; Piérard-Franchimont C
Eur J Cancer; 1997 Oct; 33(11):1888-92. PubMed ID: 9470852
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
In 't Hout FE; Haydu LE; Murali R; Bonenkamp JJ; Thompson JF; Scolyer RA
Ann Surg; 2012 Jun; 255(6):1165-70. PubMed ID: 22566014
[TBL] [Abstract][Full Text] [Related]
26. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
[TBL] [Abstract][Full Text] [Related]
28. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.
Carnochan P; Briggs JC; Westbury G; Davies AJ
Br J Cancer; 1991 Jul; 64(1):102-7. PubMed ID: 1854608
[TBL] [Abstract][Full Text] [Related]
29. Novel role for RGS1 in melanoma progression.
Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
[TBL] [Abstract][Full Text] [Related]
32. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?
Eggermont AM; Spatz A; Lazar V; Robert C
Curr Opin Oncol; 2012 Mar; 24(2):137-40. PubMed ID: 22234255
[TBL] [Abstract][Full Text] [Related]
33. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis.
Massi D; Franchi A; Borgognoni L; Paglierani M; Reali UM; Santucci M
Virchows Arch; 2002 Jan; 440(1):22-8. PubMed ID: 11942572
[TBL] [Abstract][Full Text] [Related]
34. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
Hugdahl E; Bachmann IM; Schuster C; Ladstein RG; Akslen LA
PLoS One; 2019; 14(1):e0210399. PubMed ID: 30640942
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
Leiter U; Buettner PG; Eigentler TK; Garbe C
J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
[TBL] [Abstract][Full Text] [Related]
37. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
Francken AB; Shaw HM; Thompson JF; Soong SJ; Accortt NA; Azzola MF; Scolyer RA; Milton GW; McCarthy WH; Colman MH; McGovern VJ
Ann Surg Oncol; 2004 Apr; 11(4):426-33. PubMed ID: 15070604
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma.
Warso MA; Maniotis AJ; Chen X; Majumdar D; Patel MK; Shilkaitis A; Gupta TK; Folberg R
Clin Cancer Res; 2001 Mar; 7(3):473-7. PubMed ID: 11297236
[TBL] [Abstract][Full Text] [Related]
39. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
[TBL] [Abstract][Full Text] [Related]
40. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
Moehrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
